image
Healthcare - Biotechnology - NASDAQ - US
$ 29.74
-2.14 %
$ 3.7 B
Market Cap
-14.65
P/E
APLS - STOCK-BASED COMPENSATION

Stock-based Compensation APLS - Apellis Pharmaceuticals, Inc.

image
106 M
LAST VALUE
22.44%
2 YEAR CAGR
68.79%
5 YEAR CAGR
81.58%
10 YEAR CAGR